Page 7 - Stan Erck News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MONEYWEB app instead? US now has a Covid-19 mutation that likely confers partial resistance to antibodies produced by vaccines. By Robert Langreth, Bloomberg 1 Feb 2021  12:30  Image: Bloomberg A Covid-19 mutation that likely confers partial resistance to the antibodies produced by vaccines is now in the US, spurring scientists to probe new ways to battle a disease that’s constantly changing and could remain active for years. The South African variant has already spread quickly across the African continent and has been seen in at least 24 countries outside of Africa. It was reporte...

Variants Spreading in U.S. Fan the Need to ‘Crush’ Covid Quickly Bloomberg 2/1/2021 Robert Langreth © Bloomberg A pharmacist prepares a dose of the Pfizer BioNtech Covid-19 vaccine at a mass vaccination site at Fenway Park in Boston, Massachusetts, U.S., on Friday, Jan. 29, 2021. In addition to 20,000 vaccination appointments that went live at Gillette Stadium and Fenway Park on Thursday morning, Govenor Baker said 15,000 more appointments had been made available at the Springfield and Danvers sites, which were "being booked." (Bloomberg) -- A Covid-19 mutation that ...

Mutations that likely confer partial resistance to vaccines and antibody treatments are now prevalent in both South Africa and Brazil, and they are threatening to spread worldwide.

Variants Spreading in U.S. Fan the Need to ‘Crush’ Covid Quickly Bloomberg 2/1/2021 Robert Langreth © Bloomberg A pharmacist prepares a dose of the Pfizer BioNtech Covid-19 vaccine at a mass vaccination site at Fenway Park in Boston, Massachusetts, U.S., on Friday, Jan. 29, 2021. In addition to 20,000 vaccination appointments that went live at Gillette Stadium and Fenway Park on Thursday morning, Govenor Baker said 15,000 more appointments had been made available at the Springfield and Danvers sites, which were "being booked." (Bloomberg) -- A Covid-19 mutation that ...

WASHINGTON (BLOOMBERG) - The world could be on the verge of having two more vaccines to fight the Covid-19 pandemic, but virus variants popping up worldwide are forcing companies that make the shots to develop boosters for a disease that could remain active for years. Vaccines made by Moderna Inc and the Pfizer Inc-BioNTech SE partnership are already in use. Meanwhile, new studies show that two more - from Johnson & Johnson and Novavax Inc - pack potent punches against early forms of the virus, potentially paving the way for quick authorisations in the US for J&J's vaccine and in the UK for N...